Tonix Pharma up 3% on smallpox progress

|About: Tonix Pharmaceuticals Ho... (TNXP)|By:, SA News Editor

Research published today describes the successful synthesis and characterization of a potential smallpox-preventing vaccine based on horsepox virus.

The company is developing a synthetic version of horsepox virus from cell culture (TNX-801) as a potential vaccine for smallpox in humans.

Source: Press Release

TNXP +3.3%

Subscribe for full text news in your inbox